Loading clinical trials...

The Effects of Physical Activity on Patients With Inflammatory Bowel Disease | Clinical Trials | Clareo Health

COMPLETED

The Effects of Physical Activity on Patients With Inflammatory Bowel Disease

NCT02222584•Yonsei University

Summary

Physical activity (PA) is beneficial in the prevention and management of chronic disease. However, few data exist regarding the level of PA in inflammatory bowel disease (IBD) and whether or not vigorous PA may have beneficial effects on patients' health. To evaluate the level of PA and the effect of PA on disease activity of patients with IBD. To evaluate the effect of PA on quality of life of patients with IBD.

Eligibility

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age ≥ 19
•patients with inflammatory bowel disease (Crohn's disease, Ulcerative Colitis, intestinal behcet's disease)

Exclusion Criteria

•Age \<19
•Patient who denied to response the survey questions
•Patient who denied to enroll the survey research

Locations (1)

Severance Hospital

Seoul, South Korea

Key Dates

Start Date

July 1, 2014

Primary Completion Date

February 1, 2018

Completion Date

February 1, 2018

Last Updated

March 27, 2019

Enrollment

158

ACTUAL participants

Conditions

Inflammatory Bowel Disease

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883

Inflammatory Bowel DiseasesCrohn's Disease

View study

RECRUITINGNA

Impact of Morning Light Therapy in IBD

NCT07207200

Inflammatory Bowel Disease

View study

RECRUITING

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Effects of Physical Activity on Patients With Inflammatory Bowel Disease

Inclusion Criteria

Exclusion Criteria

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Impact of Morning Light Therapy in IBD

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

A Phase I Study of HW201877 in Healthy Subjects